Using the standard American Urological Association (AUA) antibiotic prophylaxis for penile prosthesis surgery among diabetic men with erectile dysfunction results in significantly higher likelihood of postoperative device infection and device explantation compared with nonstandard prophylaxis, suggests a recent study.
Investigational drug AMO-02 (tideglusib) has a favourable risk-benefit and pharmacokinetic profile for congenital and childhood-onset type 1 myotonic dystrophy, a recent phase II study has shown. Further studies on tideglusib are warranted.
Although continuous tube feeding is effective in enhancing the tolerance of enteral nutrition, a recent study has found not enough evidence supporting its advantage in calorie intake in patients with haemorrhagic stroke.
Inflammatory indices, such as the neutrophil-to-lymphocyte (NLR) and lymphocyte-to-monocyte (LMR) ratios, may help determine the efficacy of atezolizumab monotherapy in patients with nonsmall cell lung cancer (NSCLC), a recent study has found.
Despite advancements in stents and medication, stent thrombosis (ST) continues to occur in rare occasions following percutaneous coronary intervention (PCI), a recent study has shown. In turn, ST amplifies mortality in these patients.
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Extremes of sleep duration (≤5 or ≥10 hours/day), which is a known mortality risk factor in the general population, may increase absolute mortality in adults with type 2 diabetes (T2D), a prospective study has shown.